Results 21 to 30 of about 203,209 (118)

Advancements in the development of nucleic acid vaccines for syphilis prevention and control

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Syphilis, a chronic systemic sexually transmitted disease, is caused by the bacterium Treponema pallidum (T. pallidum). Currently, syphilis remains a widespread infectious disease with significant disease burden in many countries.
Sijia Li   +4 more
doaj   +1 more source

Insight into the current Toxoplasma gondii DNA vaccine: a review article

open access: yesExpert Review of Vaccines, 2023
Introduction Toxoplasma gondii (T.gondii) is a widespread protozoan with significant economic losses and public health importance. But so far, the protective effect of reported DNA-based vaccines fluctuates widely, and no study has demonstrated complete ...
Xirui Zhang   +8 more
doaj   +1 more source

Novel enzymatic DNA produced from a text file achieves comparable immune responses as plasmid vaccine

open access: yesnpj Vaccines
DNA vaccines have garnered considerable attention due to their recent success in humans for SARS-CoV-2 and immunotherapy for cancer. However, conventional methods for creating and manufacturing DNA vaccines at-scale are slow and rate-limiting for timely ...
James Fuller   +12 more
doaj   +1 more source

Dengue Vaccines: Current Status and Future Perspectives

open access: yesAPIK Journal of Internal Medicine
Dengue fever (DF), caused by the dengue virus (DENV), is a major public health problem worldwide, with approximately 390 million reported annual infections.
Vasantha Kamath, A. B. Aishwarya
doaj   +1 more source

Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Japanese Red Cedar (JRC) pollen induced allergy affects one third of Japanese and the development of effective therapies remains an unachieved challenge.
Yan Su   +5 more
doaj   +1 more source

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

open access: yesHuman Vaccines & Immunotherapeutics, 2017
A major advantage of DNA vaccination is the ability to induce both humoral and cellular immune responses. DNA vaccines are currently used in veterinary medicine, but have not achieved widespread acceptance for use in humans due to their low ...
John J. Suschak   +2 more
doaj   +1 more source

Novel Approach in DNA vaccine development against porcine circovirus type 2

open access: yesTheoretical and Applied Veterinary Medicine
Porcine circovirus type 2 (PCV2) is an important viral pathogen in pig populations. However, commercial vaccines cannot provide complete protection with induced humoral immunity only against disease development.
H. Wei, S. D. Lenz, R. M. Pogranichniy
doaj   +1 more source

Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Ebola virus (EBOV) infection is highly lethal and results in severe febrile bleeding disorders that affect humans and non-human primates. One of the therapeutic approaches for treating EBOV infection focus largely on cocktails of monoclonal antibodies ...
Daniel R. Ripoll   +5 more
doaj   +1 more source

Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes

open access: yesVaccines, 2020
The safety and genetic stability of V4020, a novel Venezuelan Equine Encephalitis Virus (VEEV) vaccine based on the investigational VEEV TC-83 strain, was evaluated in mice.
Dylan M. Johnson   +9 more
doaj   +1 more source

Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency

open access: yesHuman Vaccines & Immunotherapeutics, 2017
The development of safe and potent vaccines for human respiratory syncytial virus (HRSV) is still a challenge for researchers worldwide. DNA-based immunization is currently a promising approach that has been used to generate human vaccines for different ...
Mohamed A. Farrag   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy